Rep. Nadler Issues Remarks at Markup of Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act
November 20, 2019
November 20, 2019
WASHINGTON, Nov. 20 -- Rep. Jerrold Nadler, D-New York, chairman of the House Judiciary Committee, issued the following opening remarks at the markup of the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3991):
"H.R. 3991, the 'Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019,' is the second bipartisan measure we are considering today that aims to stem the tide of rising medical costs and make . . .
"H.R. 3991, the 'Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019,' is the second bipartisan measure we are considering today that aims to stem the tide of rising medical costs and make . . .